| William M Johnson Iii, MD | |
|
800 Saint Vincents Dr, North Tower Suite 600, Birmingham, AL 35205-1620 | |
| (205) 271-1600 | |
| Not Available |
| Full Name | William M Johnson Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 42 Years |
| Location | 800 Saint Vincents Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437179587 | NPI | - | NPPES |
| 000017961 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 11038 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ob-gyn Associates Of Alabama P C | 2961476254 | 5 |
News Archive
LMBRI LLC and Lipopharma Therapeutics SL today announced collaboration aimed at transforming cancer drug development and improving patient outcomes. Lipopharma developed new assessment approaches, methods and technologies for developing cancer therapeutics and diagnostics using their proprietary design of structure-based molecules that regulate the structure and functions of the membrane lipids, instead targeting cellular proteins, called "Membrane Lipid-Therapy".
Rib-X Pharmaceuticals, an antibiotics company with a broad development-stage pipeline, today announced the initiation of a Phase 2b clinical trial to evaluate delafloxacin, linezolid and vancomycin for the treatment of acute bacterial skin and skin structure infections, including infections caused by methicillin-resistant Staphylococcus aureus.
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested in humans, the discovery opens the door to a new class of therapies for this and a host of other chronic diseases.
The measure, which extended for one year this "private" approach to expanding health insurance coverage to low-income state residents, failed in four previous votes. Its opponents say the debate is not over - they are just "hitting the pause button."
A paper reporting on two cohort studies which looked at the effect of a city-wide sanitation programme on rates of childhood diarrhoea in northeast Brazil has been shortlisted for the Lancet Paper of the Year Award 2007.
› Verified 1 days ago
| Entity Name | Ob-gyn Associates Of Alabama P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346250537 PECOS PAC ID: 2961476254 Enrollment ID: O20040823001014 |
News Archive
LMBRI LLC and Lipopharma Therapeutics SL today announced collaboration aimed at transforming cancer drug development and improving patient outcomes. Lipopharma developed new assessment approaches, methods and technologies for developing cancer therapeutics and diagnostics using their proprietary design of structure-based molecules that regulate the structure and functions of the membrane lipids, instead targeting cellular proteins, called "Membrane Lipid-Therapy".
Rib-X Pharmaceuticals, an antibiotics company with a broad development-stage pipeline, today announced the initiation of a Phase 2b clinical trial to evaluate delafloxacin, linezolid and vancomycin for the treatment of acute bacterial skin and skin structure infections, including infections caused by methicillin-resistant Staphylococcus aureus.
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested in humans, the discovery opens the door to a new class of therapies for this and a host of other chronic diseases.
The measure, which extended for one year this "private" approach to expanding health insurance coverage to low-income state residents, failed in four previous votes. Its opponents say the debate is not over - they are just "hitting the pause button."
A paper reporting on two cohort studies which looked at the effect of a city-wide sanitation programme on rates of childhood diarrhoea in northeast Brazil has been shortlisted for the Lancet Paper of the Year Award 2007.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William M Johnson Iii, MD 800 Saint Vincents Dr, Suite 600, Birmingham, AL 35205-1620 Ph: (205) 271-1600 | William M Johnson Iii, MD 800 Saint Vincents Dr, North Tower Suite 600, Birmingham, AL 35205-1620 Ph: (205) 271-1600 |
News Archive
LMBRI LLC and Lipopharma Therapeutics SL today announced collaboration aimed at transforming cancer drug development and improving patient outcomes. Lipopharma developed new assessment approaches, methods and technologies for developing cancer therapeutics and diagnostics using their proprietary design of structure-based molecules that regulate the structure and functions of the membrane lipids, instead targeting cellular proteins, called "Membrane Lipid-Therapy".
Rib-X Pharmaceuticals, an antibiotics company with a broad development-stage pipeline, today announced the initiation of a Phase 2b clinical trial to evaluate delafloxacin, linezolid and vancomycin for the treatment of acute bacterial skin and skin structure infections, including infections caused by methicillin-resistant Staphylococcus aureus.
In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested in humans, the discovery opens the door to a new class of therapies for this and a host of other chronic diseases.
The measure, which extended for one year this "private" approach to expanding health insurance coverage to low-income state residents, failed in four previous votes. Its opponents say the debate is not over - they are just "hitting the pause button."
A paper reporting on two cohort studies which looked at the effect of a city-wide sanitation programme on rates of childhood diarrhoea in northeast Brazil has been shortlisted for the Lancet Paper of the Year Award 2007.
› Verified 1 days ago
James R Dollar, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 48 Medical Park Dr E, Suite 355, Birmingham, AL 35235 Phone: 205-838-3036 Fax: 205-838-5832 | |
Richard Own Burney, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-996-3130 | |
Sarah Fort Whitehead, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 2006 Brookwood Med Ctr Dr Ste 700, Birmingham, AL 35209 Phone: 205-397-1286 Fax: 205-397-1340 | |
Kimberly Hoover, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Percy Charles Hudson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 806 Saint Vincents Dr, Suite 430, Birmingham, AL 35205 Phone: 205-939-2806 | |
Isuzu Meyer, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Sarah Dunk, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |